论文部分内容阅读
链霉素在骨-关节结核的综合疗法中,是一种极有价值的药物,它既能对结核群桿菌发生影响,又可对整个机体发生影响。链霉素疗法对于骨-关节结核病人的最良好的作用,在于能使死亡率急遽的降低,这是由于之能防止和冶愈本病所常有的两个最危险合并症:在病变波及全身时的结核性脑膜炎,和在瘐管形成时的淀粉样变性。这种疗法也很明显地表现在能改善病人因全身中毒而引起的虚弱状态,并能影响骨及关节结核所并发的内脏器官的结核病变。链霉素或是与其他化学药物(对氨柳酸,异菸院,异菸肼等)并用时,既能发生抗菌作用,又能发生消炎作用。悄炎作用,在骨及关节结核时,最显著地表现在能够迅速减少或消散病灶周围渗出、浸润和血管-神经障碍,这些改变与病灶本身的变化远不一致。
Streptomycin is a valuable drug in combination therapy of bone-joint tuberculosis, which affects not only Mycobacterium tuberculosis but also the whole body. Streptomycin therapy for bone-joint tuberculosis patients the best effect is to make rapid reduction in mortality, which is due to prevent and cure the disease often the most common two of the most comorbidities: in the lesions affected Tuberculous meningitis throughout the body, and amyloidosis during ductal formation. This treatment is also obviously manifested in improving the patient’s generalized poisoning caused by the weak state, and can affect bone and joint tuberculosis complicated by the internal organs of the tuberculosis. Streptomycin, or with other chemical drugs (on the salicylic acid, isoniazid, isoniazid, etc.) and use, both antimicrobial effects, but also anti-inflammatory effect. Slipping inflammation, most notably in bone and joint tuberculosis, can rapidly reduce or eliminate exudate, infiltration and vascular-neurological disorders around the lesion, and these changes are far from consistent with changes in the lesion itself.